Skip to main content
. 2016 Sep 21;2016:6949202. doi: 10.1155/2016/6949202

Table 1.

Characteristics of participants (n = 2,724).

n %
Gender, female (n = 2,654) 1,659 62.5%

Insurance status, public (n = 2,587) 2,494 96.4

Nonsmoker (n = 2,638) 2,052 77.8

Patients with ≥1 self-reported chronic condition 1,086 39.9
 Hypertension 608 56
 Chronic pain/arthritis 257 23.7
 Heart disease 242 22.3
 Diabetes 221 20.3
 Asthma/chronic bronchitis 197 18.1
 Depression 143 13.2
 Chronic kidney disease 55 5.1

Age, mean ± SD (n = 2,644) 46.7 ± 16.8

Years of formal education, mean ± SD (n = 2,557) 12.8 ± 4.49

Number of tablets used daily, mean ± SD (n = 2,318) 2.0 ± 2.7
 Patients with ≥1 tablet daily (n = 1,467)
 ASA/aspirin 314 21.4
 Oral contraceptive 165 11.2
 Anticoagulants 80 5.5

Participating countries (n = 2,724)
 Austria° 110 4
 Finland# 107 3.9
 France, 3 sites+# 325 11.9
 Germany, 3 sites+°# 385 14.1
 Israel+ 123 4.5
 Italy, 2 sites 161 5.9
 Macedonia° 364 13.4
 Poland, 2 sites+ 241 8.8
 Slovenia° 119 4.4
 Spain+ 86 3.2
 Sweden+ 98 3.6
 Turkey, 5 sites°+ 605 22.2

°Mixed (urban/rural); +urban; #rural.